| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$438 |
Appendix 4E & 2024 Full Year Statutory Accounts
|
30 Aug 2024 9:55AM |
$0.388 |
$0.300 |
fallen by
22.58%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a loss after tax of $42,716,625 for FY2024.
- Raised approximately A$100 million through equity issuance.
- Advanced lead product eftilagimod alpha (efti) in various clinical trials.
- Secured positive regulatory feedback for Phase III TACTI-004 trial in 1L NSCLC.
- Developing LAG-3 agonist IMP761 for autoimmune diseases.
- Entered research collaborations with Monash University and Cardiff University.
- Received grants and increased interest income, contributing to financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$669 |
Appendix 4G Key to Corporate Governance Disclosure FY 24
|
30 Aug 2024 9:55AM |
$2.190 |
$2.010 |
fallen by
8.22%
|
|
| LiveHire Limited (LVH) ORDINARY FULLY PAID |
Information Technology |
- |
Supplementary Target's Statement
|
30 Aug 2024 9:54AM |
$0.046 |
$0.043 |
fallen by
6.52%
|
|
LVH - Price-sensitive ASX Announcement
Full Release
Key Points
- LiveHire Ltd signed a multi-year contract with the Australian Bureau of Statistics (ABS).
- The ABS contract will generate incremental total revenue of $2,515,932 over the contract period until 31 December 2026.
- LiveHire needs to attain Infosec Registered Assessors Program (IRAP) certification for the ABS contract, which involves significant costs and exposure to material breach conditions.
- LiveHire Directors recommend shareholders accept Humanforce's takeover offer.
- The offer price of $0.045 per share is considered compelling and provides liquidity and certain cash consideration.
- The offer is unconditional and has no superior proposals at the moment.
- All LiveHire Directors have sold their shares to Humanforce and intend to accept the offer for any future shares they acquire.
- The takeover offer by Humanforce is set to close on 30 September 2024 unless extended.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jayride Group Limited (JAY) ORDINARY FULLY PAID |
Industrials |
$2 |
FY24 Results Overview
|
30 Aug 2024 9:53AM |
$0.010 |
$0.002 |
fallen by
85%
|
|
JAY - Price-sensitive ASX Announcement
Full Release
Key Points
- Initial Strategic Review results in Q4 led to substantial improvements in profitability and cash flows.
- Contribution profit reached a record level of $708K in Q4.
- Fixed cost base was reduced by $922K in Q4, achieving $3.75 million per year in savings.
- FY25 Outlook focuses on long-term growth with a strict focus on profitability.
- Jayride is an online travel marketplace for airport transfers, serving 1,600+ airports in 110+ countries.
- Revenue for FY24 grew to a record $5.39 million.
- Strategic Review identified five key focus areas towards profitability, including cost reductions and improved supplier relationships.
- The company restructured in Q2 and Q3 to create a leaner, more profitable operation.
- Changes to capitalisation policies have been implemented, and all previously capitalised costs are now expensed.
- EBITDA and capitalised technology costs margin improved to -52% in Q4.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$49 |
Appendix 4E and Preliminary Final Report
|
30 Aug 2024 9:53AM |
$0.034 |
$0.021 |
fallen by
38.24%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited released its Appendix 4E and Preliminary Final Report for the year ended 30 June 2024.
- The company reported a net loss of $47,949,119, up 38.5% from the previous year due to increased clinical trial and research activities.
- Revenue from contracts with customers was $299,228.
- Various financial agreements and contingent considerations related to intellectual properties and licenses were detailed, potentially incurring significant future liabilities.
- Net assets decreased to $27,353,286, with cash reserves at $18,575,040.
- No dividends were declared or paid during the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saferoads Holdings Limited (SRH) ORDINARY FULLY PAID |
Industrials |
$4 |
Preliminary Final Report
|
30 Aug 2024 9:53AM |
$0.041 |
$0.095 |
risen by
131.71%
|
|
SRH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $3.82 million for the year ending June 30, 2024.
- Revenue from product sales and services totaled $12.59 million, down from $14.65 million in the previous year.
- Total comprehensive loss for the year was $3.82 million, compared to a loss of $197,407 in the previous year.
- Cash flows from operating activities were $1.03 million, down from $2.38 million the year before.
- Impairment of intangible assets amounted to $1.06 million.
- Net tangible asset backing per ordinary share decreased to 10.8 cents from 15.6 cents.
- No dividends declared for the current or previous period.
- The company breached its facility covenants with the Commonwealth Bank at June 30, 2024.
- Total equity decreased to $4.74 million from $8.14 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$394 |
Application for quotation of securities - CDP
|
30 Aug 2024 9:52AM |
$4.360 |
$4.760 |
risen by
9.17%
|
|
| Dicker Data Limited (DDR) ORDINARY FULLY PAID |
Information Technology |
$1,463 |
H1 FY2024 Results Presentation
|
30 Aug 2024 9:51AM |
$9.790 |
$8.100 |
fallen by
17.26%
|
|
DDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross revenue decreased by 0.4% to $1,590.1 million
- Q2 2024 sales growth was 8.3%
- EBITDA decreased by 2.4% to $68.9 million
- Net profit after tax fell by 5.7% to $35.4 million
- Gross profit margin improved to 9.8%
- Increased net working capital and total debt
- Total debt increased by $30.2 million
- Declared dividend increased by 108% to 26.0 cents per share
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$669 |
Appendix 4E and 2024 Full Year Statutory Accounts
|
30 Aug 2024 9:51AM |
$2.190 |
$2.010 |
fallen by
8.22%
|
|
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$700 |
Change of Director's Interest Notice
|
30 Aug 2024 9:51AM |
$3.810 |
$4.140 |
risen by
8.66%
|
|
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$700 |
Change of Director's Interest Notice
|
30 Aug 2024 9:50AM |
$3.810 |
$4.140 |
risen by
8.66%
|
|
| Australian Oil Company Limited (AOK) ORDINARY FULLY PAID |
Energy |
$2 |
Red Earth Assets Divestment & Update on Nido Transaction
|
30 Aug 2024 9:50AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
AOK - Price-sensitive ASX Announcement
Full Release
Key Points
- Agreement reached with Blue Sky Resources for cash payment of A$3m to resolve the Nido divestment transaction and divest Red Earth
- Upfront non-refundable consideration of A$750k received, with the remainder due on or before 30 November 2024
- Red Earth divested via share sale agreement of Sacgasco AB Ltd, the Company's Canadian subsidiary
- Funds from the transaction to support continued exploration operations and asset acquisitions
- Effective date of the disposal transaction upon receipt of the second tranche payment
- Settlement includes full payment of US$900,000 outstanding from the Nido divestment
- Reconciliation of the issued capital of Yilgarn Petroleum Philippines Pty Ltd and Sacgasco AB Ltd between Australian Oil and Blue Sky
- Review of operations and management conduct for the period 2021-2023 planned by the Board
- Focus remains on Californian exploration leases and future project acquisitions
- Managing Director Kane Marshall highlights the new strategy for diversifying the project portfolio
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Scentre Group (SCG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$19,220 |
Application for quotation of securities - SCG
|
30 Aug 2024 9:50AM |
$3.435 |
$3.690 |
risen by
7.42%
|
|
| Jayride Group Limited (JAY) ORDINARY FULLY PAID |
Industrials |
$2 |
Preliminary Final Report
|
30 Aug 2024 9:49AM |
$0.010 |
$0.002 |
fallen by
85%
|
|
JAY - Price-sensitive ASX Announcement
Full Release
Key Points
- Jayride Group Limited reported a total revenue and other income of $5,446,002 for the financial year ended 30 June 2024, up 4.9% from the previous year.
- The company recorded a loss after income tax expense of $8,257,194, up 1.2% from the previous year.
- Net tangible assets per ordinary security decreased to (1.79) cents from (0.17) cents in the previous period.
- There were no dividends paid, recommended, or declared during the financial period.
- The financial statements are in the process of being audited, with an anticipated unqualified audit opinion including a paragraph addressing material uncertainty related to going concern.
- Expenses included an impairment of capitalised technology costs amounting to $2,898,346.
- Total expenses for the year amounted to $13,703,196, exceeding total revenue and income.
- Cash and cash equivalents at the end of the financial year stood at $924,022, down from $2,517,966 the previous year.
- The company raised $1,790,206 in equity, net of transaction costs, during the year.
- The report includes statements of profit or loss, financial position, changes in equity, and cash flows, along with detailed notes to the financial statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SIV Capital Limited (SIV) ORDINARY FULLY PAID |
Industrials |
$7 |
SIV Capital Limited - 2024 Annual Report
|
30 Aug 2024 9:49AM |
$0.150 |
$0.150 |
fallen by
0%
|
|
| Aerometrex Limited (AMX) ORDINARY FULLY PAID |
Industrials |
$26 |
FY24 Results Presentation
|
30 Aug 2024 9:49AM |
$0.340 |
$0.275 |
fallen by
19.12%
|
|
AMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Aerometrex Limited's FY24 underlying operating revenue increased by 9.0% to $24.17 million.
- Total revenue for FY24 was $24.75 million, a 2.4% decrease from FY23.
- MetroMap subscription revenue grew by 19.3% to $8.58 million.
- LiDAR revenue increased by 10.9% to $14.15 million.
- 3D revenue fell from $2.48 million in FY23 to $0.86 million in FY24 due to softer market demand.
- New FY25 focus areas include driving MetroMap ACV and off-the-shelf sales, building a MetroMap Program Partner model, and integrating Aero Logistics' capture program.
- Aerometrex maintains a strong cash position with $8.31 million in cash.
- Emphasis on transitioning to a scalable subscription-based business model and enhancing go-to-market strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metrics Master Income Trust (MXT) ORDINARY UNITS FULLY PAID |
Financials |
$2,181 |
Appendix 4G key to Corporate Governance Disclosure FY 2024
|
30 Aug 2024 9:48AM |
$2.055 |
$2.050 |
fallen by
0.24%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$527 |
CLINUVEL Investor Webinar
|
30 Aug 2024 9:48AM |
$15.880 |
$10.520 |
fallen by
33.75%
|
|
| Global Lithium Resources Limited (GL1) ORDINARY FULLY PAID |
Materials |
$44 |
Manna DFS Metallurgical Testwork Program Completed
|
30 Aug 2024 9:48AM |
$0.245 |
$0.170 |
fallen by
30.61%
|
|
GL1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Definitive Feasibility Study (DFS) testwork program completed with 78% Li2O recovery at Manna.
- Optimisation testwork focused on desliming and flotation stages, increasing lithia recovery to 78%.
- 150 batch and two locked cycle flotation tests completed, consistently achieving >5.5% Li2O spodumene concentrate.
- Metallurgical flow sheet for the Manna DFS is now locked and finalised.
- Total increase in lithium recovery will positively impact project economics at Manna.
- Manna resource stands at 51.6Mt @ 1.0% Li2O, the second-largest lithium resource in the Kalgoorlie Lithium province.
- Whole-of-Ore (WOO) flotation process selected, improvements made to magnetic separation and mica flotation stages.
- Metallurgical testwork performed at Nagrom Laboratory, supervised by Global Lithium process team.
- Five bulk metallurgical composite samples generated using crushed PQ and HQ core.
- Testwork will continue to support impacts of site water quality over life-of-mine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aerometrex Limited (AMX) ORDINARY FULLY PAID |
Industrials |
$26 |
Aerometrex Delivers Record FY24 Underlying Revenue
|
30 Aug 2024 9:46AM |
$0.340 |
$0.275 |
fallen by
19.12%
|
|
AMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Record underlying revenue of $24.17 million for FY24.
- Statutory revenue down 2.4% to $24.75 million.
- MetroMap subscription revenue grew by 19.3% to $8.58 million.
- LiDAR revenue increased by 10.9% to $14.15 million.
- 3D revenue dropped by 65.3% to $0.86 million.
- Cash balance stands at $8.31 million.
- Notable contract awards include $1.45 million with Agronomeye and $1 million with Queensland Government.
- Introduction of new technology like IGI DigiCam 450 MetroMap sensor.
- Focus on subscription-based business model with subscription revenue now 34.7% of total group revenue.
- Challenges faced due to no significant off-the-shelf MetroMap and 3D sales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genetic Technologies Limited (GTG) ORDINARY FULLY PAID |
Health Care |
$6 |
Preliminary Final Report
|
30 Aug 2024 9:46AM |
$0.039 |
$0.039 |
fallen by
0%
|
|
GTG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for ordinary activities was down 12% to $7,664,784.
- Loss from ordinary activities after tax attributable to members was up 2% to $12,017,219.
- Net tangible asset backing per security decreased from 0.07 cents in 2023 to -0.24 cents in 2024.
- No dividends have been paid or declared for the current and previous financial years.
- The increased loss is attributed to higher research and development and employment expenditure.
- The group's net assets as of 30 June 2024 were $1,830,414, down from $11,162,576 in 2023.
- Cash reserves declined to $1,020,608 from $7,851,197.
- Borrowings included a secured loan of $601,000 from Radium Capital against the anticipated R&D tax incentive refund.
- Goodwill impairment was recorded mainly due to underperforming revenues in EasyDNA business.
- The consolidated statement of financial position shows a significant decline in net assets and cash reserves.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Star Entertainment Group Limited (SGR) ORDINARY FULLY PAID |
Consumer Discretionary |
$316 |
Trading Halt
|
30 Aug 2024 9:46AM |
$0.450 |
$0.110 |
fallen by
75.56%
|
|
SGR - Price-sensitive ASX Announcement
Full Release
Key Points
- The Star Entertainment Group Limited (ASX: SGR) has requested a trading halt.
- The trading halt is pending the release of an announcement by SGR.
- The trading halt will last until the earlier of the commencement of normal trading on Monday, 2 September 2024 or when the announcement is released.
- The final report from the 2024 Independent Inquiry into The Star has been provided to The Star and the NSW Independent Casino Commission.
- The Star is considering the report's implications for its financial disclosures.
- The Star is finalizing its financial results for the year ended 30 June 2024 (FY24 Results).
- The Star plans to address other matters raised in media articles about its financial and liquidity position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$14 |
FY24 Financial Results & Key Achievements Announcement
|
30 Aug 2024 9:46AM |
$0.075 |
$0.027 |
fallen by
64%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue & other income increased 26% on pcp to $19.7m
- Net cash of $6.4m as at 30 June 2024
- Access to a $15.0m debt facility to fund key growth activities
- Engineering business delivered EBITDA of $0.8m and net positive operating cashflow of $0.5m
- Rollout of three Powerhouse units contributed $1.1m to Group revenue
- Zero Lost Time Injury Rate and Zero Total Recordable Case Frequency Rate for the fourth consecutive year
- Powerhouse units delivered greater than 99.9% availability/uptime with no site visits or maintenance required
- Entered exclusive partnership with Siemens for Powerhouse technology development
- Strategic investment in Engineering capability and systems of $0.5m
- Increased investment of $0.1m in the development of Powerhouse technology
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dicker Data Limited (DDR) ORDINARY FULLY PAID |
Information Technology |
$1,463 |
H1 FY 2024 Interim Results Market Update
|
30 Aug 2024 9:45AM |
$9.790 |
$8.100 |
fallen by
17.26%
|
|
DDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross revenue for H1 2024 was $1,590.1 million, slightly down by 0.4% compared to H1 2023.
- Statutory revenue decreased by 2.1% to $1,084.5 million.
- EBITDA decreased by 2.4% to $68.9 million.
- Net profit after tax (NPAT) declined by 5.7% to $35.4 million.
- Q2 2024 gross sales grew by 8.3% quarter-on-quarter.
- Hardware and virtual services sales declined by 0.7%, while software sales increased slightly.
- The company showed resilience despite market conditions, driven by new distribution agreements and strategic vendor offerings.
- Dicker Data continues to lead in the AI sector, maintaining its position as the top Australian and New Zealand distributor for Microsoft Copilot.
- The company's statement of financial position shows an increase in working capital investment and total borrowings.
- Operating expenses increased by 6.3%, primarily due to higher salary-related costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,992 |
Application for quotation of securities - AFI
|
30 Aug 2024 9:45AM |
$7.360 |
$7.170 |
fallen by
2.58%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
